OAZIX | SBIEX | OAZIX / SBIEX | |
Total Expense Ratio | 0.75 | 1.29 | 58% |
Annual Report Gross Expense Ratio | 0.75 | 1.47 | 51% |
Fund Existence | 5 years | 39 years | - |
Gain YTD | 22.534 | 22.639 | 100% |
Front Load | N/A | 6% | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 14.4B | 171M | 8,421% |
Annual Yield % from dividends | 2.34 | 1.73 | 135% |
Returns for 1 year | 16.04 | 14.52 | 110% |
Returns for 3 years | 46.84 | 61.25 | 76% |
Returns for 5 years | N/A | 83.66 | - |
Returns for 10 years | N/A | 46.28 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
KORU | 84.66 | 2.15 | +2.61% |
Direxion Daily South Korea Bull 3X ETF | |||
IHE | 67.58 | 0.40 | +0.60% |
iShares US Pharmaceuticals ETF | |||
MAGA | 51.36 | 0.11 | +0.22% |
Point Bridge America First ETF | |||
VOOV | 191.01 | -0.19 | -0.10% |
Vanguard S&P 500 Value ETF | |||
ORCX | 30.60 | -0.38 | -1.23% |
Defiance Daily Target 2X Long ORCL ETF |